Announcements Trials
Browse Landscape

Phase

Phase 2 17Phase 4 3Phase 3 3Phase NA 2Phase 2/3 2Phase EARLY_PHASE1 1

Status

Unknown 2Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Tumor-Agnostic 1Lymphoid 1Gastrointestinal 1

Conditions

Neoplasms 1Hodgkin Disease 1Colorectal Neoplasms 1

Interventions

Dexamethasone 49Metformin 47Cyclophosphamide 42Saline Solution 38Cytarabine 34Sodium Chloride 32Bupivacaine 31Vincristine 27Cisplatin 26Propofol 25Methotrexate 25Letrozole 24Fluorouracil 24Dexmedetomidine 24Doxorubicin 23Fentanyl 22Carboplatin 22Etoposide 19Rituximab 18Morphine 18Bevacizumab 18Acetaminophen 18Lidocaine 17Granulocyte Colony-Stimulating Factor 17Prednisone 16Mercaptopurine 16Docetaxel 16Clomiphene 16Sevoflurane 15Ropivacaine 15

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 4 × OTHER × Pentoxifylline × Clear all
NCT06115174 2023-11-02

CRC - PTX

Tanta University

Phase 4 Unknown
44 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT05490953 2023-04-18

Enhancing Effect on Tumour Apoptosis With the Use of Pentoxifylline in Patients With Hodgkin Lymphoma

University of Guadalajara

Phase 4 Unknown
30 enrolled
Lymphoid

Hodgkin Disease

NCT05660694 2022-12-21

Comparison of Triamcinolone With Pentoxifylline and Vitamin- E Efficacy in the Treatment of Stage 2 and 3 Oral Submucous Fibrosis

Altamash Institute of Dental Medicine

Phase 4 Completed
40 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡